Dupilumab for maintenance treatment of uncontrolled chronic obstructive pulmonary disease with raised blood eosinophils

Purpose

Medicines recommended in NICE technology appraisals should be adopted into a local formulary if clinically appropriate and relevant to the services provided by the organisation (see NICE's medicines practice guideline on developing and updating local formularies). This template supports that process by summarising information that local formulary decision-making groups are likely to need.

Local groups have their own format of a multi-criteria decision tool, reflecting their needs. This local formulary template does not mandate any change or variation from those decision tools. Local groups can adapt this template for their own circumstances and use it to help them complete their local documents.